amongcarriersinTheNetherlands:acohort
study.Lancet.1999;353(9170):2116–2119.
288.MavrogeniS,BratisK,PapavasiliouA,etal.
CMRdetectssubclinicalcardiomyopathyin
mother-carriersofduchenneandbecker
musculardystrophy.JACCCardiovascImaging.
2013;6(4):526–528.
289.RobertsAE,NixonC,StewardCG,etal.The
barthsyndromeregistry:distinguishingdisease
characteristicsandgrowthdatafroma
longitudinalstudy.AmJMedGenetA.
2012;158A(11):2726–2732.
290.RobertsWC,SiegelRJ,McManusBM.
Idiopathicdilatedcardiomyopathy:analysisof
152necropsypatients.AmJCardiol.
1987;60(16):1340–1355.
291.KuhlU,NoutsiasM,SeebergB,SchultheissHP.
Immunohistologicalevidenceforachronic
intramyocardialinflammatoryprocessindilated
cardiomyopathy.Heart.1996;75(3):295–300.
292.CaforioAL,PankuweitS,ArbustiniE,etal.
Currentstateofknowledgeonaetiology,
diagnosis,management,andtherapyof
myocarditis:apositionstatementofthe
Europeansocietyofcardiologyworkinggroup
onmyocardialandpericardialdiseases.Eur
HeartJ.2013;34(33):2636–2648[2648a–
2648d].
293.PahlE,SleeperLA,CanterCE,etal.Incidence
ofandriskfactorsforsuddencardiacdeathin
childrenwithdilatedcardiomyopathy:areport
fromthepediatriccardiomyopathyregistry.JAm
CollCardiol.2012;59(6):607–615.
294.DaubeneyPE,NugentAW,ChondrosP,etal.
Clinicalfeaturesandoutcomesofchildhood
dilatedcardiomyopathy:resultsfromanational
population-basedstudy.Circulation.
2006;114(24):2671–2678.
295.MolinaKM,ShraderP,ColanSD,etal.
Predictorsofdiseaseprogressioninpediatric
dilatedcardiomyopathy.CircHeartFail.
2013;6(6):1214–1222.
296.HollanderSA,BernsteinD,YehJ,etal.
Outcomesofchildrenfollowingafirst
hospitalizationfordilatedcardiomyopathy.Circ
HeartFail.2012;5(4):437–443.
297.SinghTP,SleeperLA,LipshultzS,etal.
Associationofleftventriculardilationatlisting
forhearttransplantwithpostlistingandearly
posttransplantmortalityinchildrenwithdilated
cardiomyopathy.CircHeartFail.
2009;2(6):591–598.
298.EverittMD,SleeperLA,LuM,etal.Recovery
ofechocardiographicfunctioninchildrenwith
idiopathicdilatedcardiomyopathy:resultsfrom
thepediatriccardiomyopathyregistry.JAmColl
Cardiol.2014;63(14):1405–1413.
299.LuX,XieM,TomberlinD,etal.How
accurately,reproducibly,andefficientlycanwe
measureleftventricularindicesusingM-mode,
2-dimensional,and3-dimensional
echocardiographyinchildren?AmHeartJ.
2008;155(5):946–953.
300.JohnJB,CronSG,KungGC,MottAR.
Intracardiacthrombiinpediatricpatients:
presentationprofilesandclinicaloutcomes.
PediatrCardiol.2007;28(3):213–220.
301.McMahonCJ,NaguehSF,EapenRS,etal.
Echocardiographicpredictorsofadverseclinical
eventsinchildrenwithdilatedcardiomyopathy:
aprospectiveclinicalstudy.Heart.
2004;90(8):908–915.
302.WuKC,WeissRG,ThiemannDR,etal.Late
gadoliniumenhancementbycardiovascular
magneticresonanceheraldsanadverse
prognosisinnonischemiccardiomyopathy.JAm
CollCardiol.2008;51(25):2414–2421.
303.LatusH,GummelK,KlingelK,etal.Focal
myocardialfibrosisassessedbylategadolinium
enhancementcardiovascularmagneticresonance
inchildrenandadolescentswithdilated